Biolog Device Co Ltd
KOSDAQ:208710
Balance Sheet
Balance Sheet Decomposition
Biolog Device Co Ltd
Biolog Device Co Ltd
Balance Sheet
Biolog Device Co Ltd
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1 805
|
11 363
|
2 361
|
12 454
|
4 844
|
5 585
|
4 198
|
10 888
|
2 917
|
8 874
|
7 939
|
|
| Cash Equivalents |
1 805
|
11 363
|
2 361
|
12 454
|
4 844
|
5 585
|
4 198
|
10 888
|
2 917
|
8 874
|
7 939
|
|
| Short-Term Investments |
10 000
|
454
|
455
|
0
|
1 801
|
1 000
|
0
|
58
|
0
|
0
|
0
|
|
| Total Receivables |
8
|
7 903
|
21 237
|
15 088
|
33 496
|
21 368
|
26 437
|
25 248
|
27 341
|
41 428
|
33 216
|
|
| Accounts Receivables |
7
|
7 903
|
21 237
|
14 914
|
33 496
|
20 870
|
24 157
|
21 384
|
23 999
|
39 884
|
32 126
|
|
| Other Receivables |
1
|
0
|
0
|
174
|
0
|
498
|
2 280
|
3 863
|
3 342
|
1 544
|
1 089
|
|
| Inventory |
0
|
1 593
|
1 726
|
3 487
|
1 262
|
4 082
|
4 917
|
5 055
|
5 111
|
7 708
|
8 263
|
|
| Other Current Assets |
0
|
929
|
803
|
1 202
|
1 012
|
3 706
|
729
|
1 153
|
6 668
|
4 765
|
3 412
|
|
| Total Current Assets |
11 812
|
22 242
|
26 583
|
32 230
|
42 415
|
35 741
|
36 280
|
42 401
|
42 037
|
62 775
|
52 830
|
|
| PP&E Net |
0
|
17 251
|
22 966
|
24 891
|
23 417
|
32 168
|
46 461
|
45 517
|
31 962
|
43 393
|
29 798
|
|
| PP&E Gross |
0
|
0
|
0
|
24 891
|
0
|
32 168
|
46 461
|
45 517
|
31 962
|
43 393
|
29 798
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
14 019
|
0
|
27 648
|
33 427
|
42 918
|
43 957
|
49 760
|
52 666
|
|
| Intangible Assets |
0
|
1 111
|
1 097
|
1 377
|
2 440
|
311
|
355
|
4 630
|
4 319
|
458
|
441
|
|
| Goodwill |
0
|
0
|
0
|
1 252
|
0
|
0
|
0
|
1 637
|
1 486
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
11
|
0
|
250
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
896
|
1 098
|
954
|
6 918
|
17 604
|
15 736
|
2 290
|
4 321
|
42
|
14 408
|
|
| Other Long-Term Assets |
0
|
862
|
898
|
3 209
|
1 364
|
2 845
|
2 310
|
7 296
|
1 930
|
1 483
|
1 420
|
|
| Other Assets |
0
|
0
|
0
|
1 252
|
0
|
0
|
0
|
1 637
|
1 486
|
0
|
0
|
|
| Total Assets |
11 812
N/A
|
42 362
+259%
|
52 641
+24%
|
63 923
+21%
|
76 554
+20%
|
88 919
+16%
|
101 142
+14%
|
103 770
+3%
|
86 055
-17%
|
108 150
+26%
|
98 899
-9%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
3 768
|
7 908
|
4 497
|
7 359
|
10 866
|
16 456
|
11 909
|
14 428
|
33 869
|
25 959
|
|
| Accrued Liabilities |
0
|
0
|
0
|
444
|
0
|
465
|
435
|
538
|
300
|
467
|
746
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11 371
|
9 160
|
12 743
|
14 620
|
|
| Current Portion of Long-Term Debt |
0
|
3 639
|
3 925
|
1 895
|
16 802
|
15 794
|
17 869
|
16 433
|
6 878
|
453
|
466
|
|
| Other Current Liabilities |
4
|
2 370
|
3 298
|
3 259
|
3 544
|
3 249
|
3 163
|
9 286
|
2 843
|
2 415
|
3 011
|
|
| Total Current Liabilities |
4
|
9 776
|
15 132
|
10 095
|
27 705
|
30 374
|
37 923
|
49 537
|
33 610
|
49 947
|
44 802
|
|
| Long-Term Debt |
1 708
|
3 735
|
891
|
11 892
|
2 791
|
2 411
|
21 894
|
4 079
|
320
|
671
|
247
|
|
| Deferred Income Tax |
40
|
0
|
0
|
0
|
0
|
0
|
0
|
709
|
827
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
343
|
388
|
0
|
0
|
74
|
67
|
3 302
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3 674
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1 751
N/A
|
13 511
+672%
|
16 023
+19%
|
21 644
+35%
|
30 108
+39%
|
32 785
+9%
|
63 491
+94%
|
54 251
-15%
|
34 824
-36%
|
47 316
+36%
|
45 049
-5%
|
|
| Equity | ||||||||||||
| Common Stock |
510
|
2 550
|
2 740
|
2 740
|
2 757
|
2 887
|
2 887
|
4 143
|
4 225
|
6 260
|
6 590
|
|
| Retained Earnings |
16
|
16 201
|
22 689
|
26 148
|
32 038
|
37 559
|
20 682
|
8 480
|
8 738
|
1 619
|
11 373
|
|
| Additional Paid In Capital |
9 411
|
8 080
|
11 321
|
15 270
|
11 853
|
17 762
|
19 208
|
35 937
|
36 949
|
54 810
|
56 476
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
1 492
|
3 101
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
62
|
0
|
351
|
275
|
0
|
0
|
0
|
0
|
|
| Other Equity |
156
|
2 020
|
132
|
1 818
|
201
|
232
|
1 749
|
959
|
1 319
|
1 383
|
2 157
|
|
| Total Equity |
10 061
N/A
|
28 851
+187%
|
36 618
+27%
|
42 279
+15%
|
46 447
+10%
|
56 133
+21%
|
37 651
-33%
|
49 519
+32%
|
51 231
+3%
|
60 834
+19%
|
53 850
-11%
|
|
| Total Liabilities & Equity |
11 812
N/A
|
42 362
+259%
|
52 641
+24%
|
63 923
+21%
|
76 554
+20%
|
88 919
+16%
|
101 142
+14%
|
103 770
+3%
|
86 055
-17%
|
108 150
+26%
|
98 899
-9%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
1
|
5
|
5
|
5
|
6
|
6
|
6
|
8
|
8
|
13
|
13
|
|